Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Dermatophytic Onychomycosis Treatment Market, by region, 2020-2030 (USD Billion)
1.2.2. Dermatophytic Onychomycosis Treatment Market, by Product Type, 2020-2030 (USD Billion)
1.2.3. Dermatophytic Onychomycosis Treatment Market, by Route of Administration, 2020-2030 (USD Billion)
1.2.4. Dermatophytic Onychomycosis Treatment Market, by Type, 2020-2030 (USD Billion)
1.2.5. Dermatophytic Onychomycosis Treatment Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Dermatophytic Onychomycosis Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Dermatophytic Onychomycosis Treatment Market Dynamics
3.1. Dermatophytic Onychomycosis Treatment Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing awareness of dermatophytic onychomycosis and its treatment
3.1.1.2. Rising aging population
3.1.1.3. Growing prevalence of onychomycosis
3.1.2. Market Challenges
3.1.2.1. High cost of treatment
3.1.2.2. Side effects of treatment
3.1.3. Market Opportunities
3.1.3.1. Increasing government support for research and development
3.1.3.2. Rising introduction of new and innovative treatments
Chapter 4. Global Dermatophytic Onychomycosis Treatment Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Dermatophytic Onychomycosis Treatment Market, by Product Type
5.1. Market Snapshot
5.2. Global Dermatophytic Onychomycosis Treatment Market by Product Type, Performance – Potential Analysis
5.3. Global Dermatophytic Onychomycosis Treatment Market Estimates & Forecasts by Product Type 2020-2030 (USD Billion)
5.4. Dermatophytic Onychomycosis Treatment Market, Sub Segment Analysis
5.4.1. Tablets
5.4.2. Nail Paints
Chapter 6. Global Dermatophytic Onychomycosis Treatment Market, by Route of Administration
6.1. Market Snapshot
6.2. Global Dermatophytic Onychomycosis Treatment Market by Route of Administration, Performance – Potential Analysis
6.3. Global Dermatophytic Onychomycosis Treatment Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
6.4. Dermatophytic Onychomycosis Treatment Market, Sub Segment Analysis
6.4.1. Oral
6.4.2. Topical
Chapter 7. Global Dermatophytic Onychomycosis Treatment Market, by Type
7.1. Market Snapshot
7.2. Global Dermatophytic Onychomycosis Treatment Market by Type, Performance – Potential Analysis
7.3. Global Dermatophytic Onychomycosis Treatment Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
7.4. Dermatophytic Onychomycosis Treatment Market, Sub Segment Analysis
7.4.1. Prescribed
7.4.2. Over-the-Counter (OTC)
Chapter 8. Dermatophytic Onychomycosis Treatment Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Dermatophytic Onychomycosis Treatment Market by Distribution Channel, Performance – Potential Analysis
8.3. Global Dermatophytic Onychomycosis Treatment Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
8.4. Dermatophytic Onychomycosis Treatment Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Online Channels
Chapter 9. Global Dermatophytic Onychomycosis Treatment Market, Regional Analysis
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Dermatophytic Onychomycosis Treatment Market, Regional Market Snapshot
9.4. North America Dermatophytic Onychomycosis Treatment Market
9.4.1. U.S. Dermatophytic Onychomycosis Treatment Market
9.4.1.1. Product Type breakdown estimates & forecasts, 2020-2030
9.4.1.2. Route of Administration breakdown estimates & forecasts, 2020-2030
9.4.1.3. Type breakdown estimates & forecasts, 2020-2030
9.4.1.4. Distribution Channel breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Dermatophytic Onychomycosis Treatment Market
9.5. Europe Dermatophytic Onychomycosis Treatment Market Snapshot
9.5.1. U.K. Dermatophytic Onychomycosis Treatment Market
9.5.2. Germany Dermatophytic Onychomycosis Treatment Market
9.5.3. France Dermatophytic Onychomycosis Treatment Market
9.5.4. Spain Dermatophytic Onychomycosis Treatment Market
9.5.5. Italy Dermatophytic Onychomycosis Treatment Market
9.5.6. Rest of Europe Dermatophytic Onychomycosis Treatment Market
9.6. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Snapshot
9.6.1. China Dermatophytic Onychomycosis Treatment Market
9.6.2. India Dermatophytic Onychomycosis Treatment Market
9.6.3. Japan Dermatophytic Onychomycosis Treatment Market
9.6.4. Australia Dermatophytic Onychomycosis Treatment Market
9.6.5. South Korea Dermatophytic Onychomycosis Treatment Market
9.6.6. Rest of Asia Pacific Dermatophytic Onychomycosis Treatment Market
9.7. Latin America Dermatophytic Onychomycosis Treatment Market Snapshot
9.7.1. Brazil Dermatophytic Onychomycosis Treatment Market
9.7.2. Mexico Dermatophytic Onychomycosis Treatment Market
9.8. Middle East & Africa Dermatophytic Onychomycosis Treatment Market
9.8.1. Saudi Arabia Dermatophytic Onychomycosis Treatment Market
9.8.2. South Africa Dermatophytic Onychomycosis Treatment Market
9.8.3. Rest of Middle East & Africa Dermatophytic Onychomycosis Treatment Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Bausch Health Companies Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Pfizer Inc.
10.3.3. Galderma S.A
10.3.4. GlaxoSmithKline plc
10.3.5. Janssen Pharmaceuticals, Inc.
10.3.6. Cipla Inc.
10.3.7. Kaken Pharmaceuticals Co., Ltd.
10.3.8. Novan, Inc.
10.3.9. Anacor Pharmaceuticals, Inc.
10.3.10. Moberg Pharma AB
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
